{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T10:29:28Z","timestamp":1760956168555,"version":"3.40.5"},"reference-count":31,"publisher":"Veterinary World","license":[{"start":{"date-parts":[[2022,10,7]],"date-time":"2022-10-07T00:00:00Z","timestamp":1665100800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2022,10,7]],"date-time":"2022-10-07T00:00:00Z","timestamp":1665100800000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2022,10,7]],"date-time":"2022-10-07T00:00:00Z","timestamp":1665100800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vet World"],"abstract":"<jats:p>Background and Aim: African horse sickness (AHS) is a non-contagious, high mortality, and insect-borne disease caused by a double-stranded RNA virus from the genus Orbivirus. The study aimed to develop inactivated vaccines serotype 1 inactivated AHS vaccine (IAV) and to compare the effect of IAV on antibody responses in young na\u00efve horses and adult horses pre-immunized with live-attenuated AHS virus (AHSV) serotypes 1, 3, and 4 live-attenuated vaccine (LAV).\n\nMaterials and Methods: A total of 27 horses were vaccinated in two trials. Twelve AHS na\u00efve young horses and 15 adult horses were divided into three groups of 4 and 5 horses each, respectively. Horses in control Group 1 were treated with phosphate-buffered saline. Horses in Group 2 were subcutaneously vaccinated with 2 mL of formulated IAV with 10% Gel 01\u2122 (Seppic, France) on day 0 and horses in Group 3 were subcutaneously vaccinated with 2 mL of IAV on day 0 and a booster on day 28. The IAV vaccine was prepared by isolating the AHSV serotype 1 growing on Vero cells, 10\u00d7 virus titer was concentrated by ultrafiltration and chemically killed by formalin, using 10% Gel 01\u2122 as an adjuvant. Ethylenediaminetetraacetic acid blood samples were taken for hematology, blood biochemistry, and antibody titers using an immunoperoxidase monolayer assay on 158th day post-vaccination.\n\nResults: Vaccination with IAV serotype 1 in adult horses pretreated with LAV increased antibody titers more than in young na\u00efve vaccinated horses. The total leukocyte count and %neutrophils significantly increased, while %lymphocytes and %eosinophils significantly decreased on day 1 after vaccination; no local reactions were observed at the site of injection in any group. All biochemical and electrolyte analyte values were within the normal range after vaccination.\n\nConclusion: The formulation of IAV serotype 1 using Gel 01\u2122 as an adjuvant is safe and induces high antibody titers. This IAV formulation induced a high antibody response in horses without causing local reactions and mild systemic effects. However, AHS na\u00efve horses still required \u22652 vaccinations and an annual booster vaccination to achieve high antibody titers.<\/jats:p>","DOI":"10.14202\/vetworld.2022.2365-2375","type":"journal-article","created":{"date-parts":[[2022,10,7]],"date-time":"2022-10-07T07:31:24Z","timestamp":1665127884000},"page":"2365-2375","source":"Crossref","is-referenced-by-count":1,"title":["Comparative immune responses after vaccination with the formulated inactivated African horse sickness vaccine serotype 1 between na\u00efve horses and pretreated horses with the live-attenuated African horse sickness vaccine"],"prefix":"10.14202","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3207-0885","authenticated-orcid":false,"given":"Narongsak","family":"Chaiyabutr","sequence":"first","affiliation":[{"name":"Department of Research and Development, Queen Saovabha Memorial Institute, Thai Red Cross Society, Bangkok, Thailand; Department of Physiology, Faculty of Veterinary Science, Chulalongkorn University, Bangkok, Thailand."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2251-1314","authenticated-orcid":false,"given":"Suphot","family":"Wattanaphansak","sequence":"additional","affiliation":[{"name":"Department of Veterinary Medicine, Faculty of Veterinary Science Chulalongkorn University, Bangkok, Thailand."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5465-8735","authenticated-orcid":false,"given":"Rachod","family":"Tantilerdcharoen","sequence":"additional","affiliation":[{"name":"Veterinary Diagnostic Laboratory, Faculty of Veterinary Science Chulalongkorn University, Bangkok, Thailand."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5283-8169","authenticated-orcid":false,"given":"Surasak","family":"Akesowan","sequence":"additional","affiliation":[{"name":"Horse Farm and Laboratory Animal Breeding Centre, Queen Saovabha Memorial Institute, Thai Red Cross Society, Petchaburi, Thailand."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8217-7843","authenticated-orcid":false,"given":"Suraseha","family":"Ouisuwan","sequence":"additional","affiliation":[{"name":"Horse Farm and Laboratory Animal Breeding Centre, Queen Saovabha Memorial Institute, Thai Red Cross Society, Petchaburi, Thailand."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8750-5364","authenticated-orcid":false,"given":"Darm","family":"Naraporn","sequence":"additional","affiliation":[{"name":"Horse Farm and Laboratory Animal Breeding Centre, Queen Saovabha Memorial Institute, Thai Red Cross Society, Petchaburi, Thailand."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"5308","published-online":{"date-parts":[[2022,10,7]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"Mellor, P.S. and Hamblin, C. (2004) African horse sickness. Vet. Res., 35(4): 445\u2013466.","DOI":"10.1051\/vetres:2004021"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Diouf, N.D., Etter, E., Lo, M.M., Lo, M. and Akakpo, A.J. (2012) Outbreaks of African horse sickness in Senegal, and methods of control of the 2007 epidemic. Vet. Rec., 172(6): 152.","DOI":"10.1136\/vr.101083"},{"key":"ref2","unstructured":"Fern\u00e1ndez, P.J. and White, W.R. (2010) African horse sickness. In: Fern\u00e1ndez, P.J. and White, W.R. editors. Atlas of Transboundary Animal Diseases. OIE, Paris. p11\u201318."},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Erasmus, B.J. (1973) The pathogenesis of African horse sickness. In: Bryans, J.T. and Gerber, H., editors. Equine Infectious Diseases. 3rd ed., Vol. 3. Proceedings International Conference Equine Infectious, Diseases, Paris, France, Karger Publishers, Switzerland. p1\u201311.","DOI":"10.1159\/000393512"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Dennis, S.J., Meyers, A.E., Hitzeroth, I.I. and Rybicki, E.P. (2019) African horse sickness: A review of current understanding and vaccine development. Viruses, 11(9): 844.","DOI":"10.3390\/v11090844"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"Wittmann, E.J. and Baylis, M. (2000) Climate change: Effects on culicoides-transmitted viruses and implications for the UK. Vet. J., 160(2): 107\u2013117.","DOI":"10.1016\/s1090-0233(00)90470-2"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"Lu, G., Pan, J., Ou, J., Shao, R., Hu, X., Wang, C. and Li, S. (2020) African horse sickness: Its emergence in Thailand and potential threat to other Asian countries. Trans. Emerg. Dis., 67(5): 1751\u20131753.","DOI":"10.1111\/tbed.13625"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Gao, S., Zeng, Z., Wang, H.N., Chen, F.Y., Huang, L.Y. and Wang, X.L. (2022) Predicting the possibility of African horse sickness (AHS) introduction into China using spatial risk analysis and habitat connectivity of Culicoides. Sci. Rep., 12 : 3910.","DOI":"10.1038\/s41598-022-07512-w"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"Weyer, C.T., Grewar, J.D., Burger, P., Rossouw, E., Lourens, C., Joone, C., le Grange, M., Coetzee, P., Venter, E., Martin, D.P., MacLachlan, N.J. and Guthrie, A.J. (2016) African horse sickness caused by genome reassortment and reversion to virulence of live, attenuated vaccine viruses, South Africa, 2004\u20132014. Emerg. Infect Dis., 22(12):2087\u20132096.","DOI":"10.3201\/eid2212.160718"},{"key":"ref9","unstructured":"Laegreid, W.W. (1996) African horse sickness. In: Studdert, M.J., editor. Virus Infections of Vertebrates, Virus Infections of Equines. Vol. 6. Elsevier Press, Amsterdam. p101\u2013123."},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"Dudourget, P., Preaud, J.M., Detraz, F., Lacoste, A.C., Erasmus, B.J. and Lombard, M. (1992) Development, production and quality control of an industrial inactivated vaccine against African horse sickness virus Type 4. In: Walton, T.W. and Osburn, B.I., editors. Bluetongue, African Horse Sickness and Related Orbiviruses. CRC Press, Boca Raton. p874\u2013886.","DOI":"10.1016\/0007-1935(92)90075-c"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"House, J.A., Lombard, M., Dubourget, P., House, C. and Mebus, C.A. (1994) Further studies on the efficacy of an inactivated African horse sickness Type 4 vaccine. Vaccine, 12(2): 142\u2013144.","DOI":"10.1016\/0264-410x(94)90052-3"},{"key":"ref12","unstructured":"OIE. (2018) African horse sickness. In: Manual of Diagnostic Tests and Vaccines for Terrestrial Animals. 8th ed. OIE, Paris. p1237\u20131252."},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"Dubourget, P., Preaud, J.M., Detraz, N., Lacoste, F., Fabry, A.C., Erasmus, B.J. and Lombard, M. (1992) Development, production, and quality control of an industrial inactivated vaccine against African horse sickness virus Type 4. In: Walton, T.E. and Osburn, B.I., editors. Bluetongue, African Horse Sickness and Related Orbiviruses. Proceedings of the 2nd International Symposium. CRC Press, Boca Raton. p874\u2013886.","DOI":"10.1016\/0007-1935(92)90075-c"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"House, J.A., Lombard, M., House, C., Dubourget, P. and Mebus, CA. (1992) Efficacy of an inactivated vaccine for African horse sickness serotype 4. In: Walton, T.W. and Osburn, B.I., editors. Bluetongue, African Horse Sickness and Related Orbiviruses. CRC Press, Boca Raton. p891\u2013895.","DOI":"10.1016\/0264-410x(94)90052-3"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"Wattanaphansak, S., Singer, R.S. and Gebhart, C.J. (2009) In vitro antimicrobial activity against 10 North American and European Lawsonia intracellularis isolates. Vet. Microbiol., 134(3\u20134): 305\u2013310.","DOI":"10.1016\/j.vetmic.2008.08.007"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Roy, P. (2017) Bluetongue virus structure and assembly. Curr. Opin. Virol., 24 : 115\u2013123.","DOI":"10.1016\/j.coviro.2017.05.003"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"Stevens, L.M., Moffat, K., Cooke, L., Nomikou, K., Mertens, P.P.C., Jackson, T. and Darpel, K.E. (2019) A low-passage insect-cell isolate of bluetongue virus uses a macropinocytosis-like entry pathway to infect natural target cells derived from the bovine host. J. Gen. Virol., 100(4): 568\u2013582.","DOI":"10.1099\/jgv.0.001240"},{"key":"ref18","unstructured":"American Veterinary Medical Association. (2006) Backgrounder: African Horse Sickness. Available from: https:\/\/www.avma.org. Retrieved on 15-01-2022."},{"key":"ref19","unstructured":"Coetzer, J.A. and Guthrie, A.J. (2004). African horse sickness. In: Coetzer, J.A. and Tustin, R.C., editors. Infectious Diseases of Livestock. 2nd ed. Oxford University Press, Cape Town. p1231\u20131246."},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"Gilfoyle, D. (2006) Veterinary immunology as colonial science: Method and quantification in the investigation of horse sickness in South Africa, C. 1905\u20131945. J. Hist. Med. Allied Sci., 61(1): 26\u201365.","DOI":"10.1093\/jhmas\/jrj002"},{"key":"ref21","unstructured":"Mshelia, W.P., Abdussamad, A.M. and Lazarus, D.D. (2008) African Horse Sickness Vaccine Failure in a Five Year Old Polo Mare: A Case Report. Conference, Paper. Available from: https:\/\/www.research\/gate.net\/publication\/235975315. Retrieved on 10-10-2021."},{"key":"ref22","unstructured":"Sellon, D.S. (1999) Haematopoietic and immune systems. In: Mair, T., Love, S., Schumacher, J. and Watson, E., editors. Equine Medicine, Surgery and Reproduction. Harcourt Brace and Company, London. p191\u2013206."},{"key":"ref23","unstructured":"Wilson, W.D., Kanara, E.W., Spensley, M.S., Powell, D.G., Files, W.S. and Steckel, R.R. (1995) Guidelines for vaccination of horses. J. Am. Vet. Med. Assoc., 207(4): 426\u2013431."},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"Van Rijn, P.A., Maris-Veldhuis, M.A., Grobler, M., Wright, I.M., Erasmus, B.J., Maartens, L.H. and Potgieter, C.A. (2020) Safety and efficacy of inactivated African horse sickness (AHS) vaccine formulated with different adjuvants. Vaccine, 38(45): 7108\u20137117.","DOI":"10.1016\/j.vaccine.2020.08.072"},{"key":"ref25","unstructured":"Ronchi, G.F., Ulisse, S., Rossi, E., Franchi, P., Armillotta, G., Capista, S., Peccio, A., Ventura, M.D. and Pini, A. (2012) Immunogenicity of two adjuvant formulations of an inactivated African horse sickness vaccine in guinea-pigs and target animals. Vet. Ital., 48(1): 55\u201376."},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"Lelli, R., Molini, U., Ronchi, G.F., Rossi, E., Franchi, P., Ulisse, S., Armillotta, G., Capista, S., Khaiseb, S., Ventura, M.D. and Pini, A. (2013) Inactivated and adjuvanted vaccine for the control of the African horse sickness virus serotype 9 infection: Evaluation of efficacy in horses and guinea-pig model. Vet. Ital., 49(1): 89\u201398.","DOI":"10.1016\/j.jviromet.2008.07.007"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"Mathebula, E.M., Faber, F.E., van Wyngaardt, W., van Schalkwyk, A., Pretorius, A. and Fehrsen, J. (2017) B-cell epitopes of African horse sickness virus serotype 4 recognised by immune horse sera. Onderstepoort J. Vet. Res., 84(1): e1\u2013e12.","DOI":"10.4102\/ojvr.v84i1.1313"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"Rodr\u00edguez, M., Joseph, S., Pfeffer, M., Raghavan, R. and Wernery, U. (2020) Immune response of horses to inactivated African horse sickness vaccines. BMC Vet. Res., 16(1): 322.","DOI":"10.1186\/s12917-020-02540-y"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"Lef\u00e8vre, P.C., Mellor, P. and Saegerman, C.L. (2010) Bluetongue. In: Lef\u00e8vre, P.C., Blancou, J., Chermette, R. and Uilenberg, G., editors. Infectious and Parasitic Diseases of Livestock. Vol. 1. Lavoisier, Paris. p663\u2013688.","DOI":"10.1079\/9782743008727.0000"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"Wernery, U., Joseph, S., Raghavan, R., Dyer, B. and Spendrup, S. (2020) African Horse sickness fever in vaccinated horses: Short communication. J. Equine Vet. Sci., 88 : 102967.","DOI":"10.1016\/j.jevs.2020.102967"}],"container-title":["Veterinary World"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.veterinaryworld.org\/Vol.15\/October-2022\/1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.veterinaryworld.org\/Vol.15\/October-2022\/1.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"text-mining"},{"URL":"http:\/\/www.veterinaryworld.org\/Vol.15\/October-2022\/1.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T17:22:24Z","timestamp":1669310544000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.veterinaryworld.org\/Vol.15\/October-2022\/1.html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,7]]},"references-count":31,"URL":"https:\/\/doi.org\/10.14202\/vetworld.2022.2365-2375","relation":{},"ISSN":["2231-0916","0972-8988"],"issn-type":[{"type":"electronic","value":"2231-0916"},{"type":"print","value":"0972-8988"}],"subject":[],"published":{"date-parts":[[2022,10,7]]}}}